VOYA Investment Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-9,960
| Closed | -$246K | – | 2736 |
|
|
2024
Q3 | $246K | Buy |
9,960
+57
| +0.6% | +$1.48K | ﹤0.01% | 2366 |
|
|
2024
Q2 | $251K | Buy |
+9,903
| New | +$257K | ﹤0.01% | 2351 |
|
|
2022
Q1 | – | Sell |
-5,737
| Closed | -$206K | – | 2653 |
|
|
2021
Q4 | $206K | Sell |
5,737
-7,293
| -56% | -$292K | ﹤0.01% | 2493 |
|
|
2021
Q3 | $555K | Buy |
13,030
+220
| +2% | +$9.06K | ﹤0.01% | 1990 |
|
|
2021
Q2 | $555K | Sell |
12,810
-765
| -6% | -$32.6K | ﹤0.01% | 2021 |
|
|
2021
Q1 | $554K | Buy |
13,575
+3,075
| +29% | +$117K | ﹤0.01% | 1967 |
|
|
2020
Q4 | $475K | Buy |
10,500
+1,126
| +12% | +$42.7K | ﹤0.01% | 1951 |
|
|
2020
Q3 | $332K | Sell |
9,374
-92
| -1% | -$3.32K | ﹤0.01% | 1886 |
|
|
2020
Q2 | $357K | Sell |
9,466
-5,454
| -37% | -$180K | ﹤0.01% | 1874 |
|
|
2020
Q1 | $431K | Buy |
14,920
+425
| +3% | +$17.2K | ﹤0.01% | 1702 |
|
|
2019
Q4 | $752K | Buy |
14,495
+522
| +4% | +$30.3K | ﹤0.01% | 1632 |
|
|
2019
Q3 | $767K | Sell |
13,973
-67
| -0.5% | -$3.44K | ﹤0.01% | 1488 |
|
|
2019
Q2 | $570K | Sell |
14,040
-139
| -1% | -$5.07K | ﹤0.01% | 1686 |
|
|
2019
Q1 | $429K | Buy |
14,179
+7,733
| +120% | +$265K | ﹤0.01% | 1865 |
|
|
2018
Q4 | $217K | Hold |
6,446
| – | – | ﹤0.01% | 2186 |
|
|
2018
Q3 | $272K | Hold |
6,446
| – | – | ﹤0.01% | 2192 |
|
|
2018
Q2 | $206K | Sell |
6,446
-680
| -10% | -$28K | ﹤0.01% | 2344 |
|
|
2018
Q1 | $354K | Sell |
7,126
-373
| -5% | -$21.1K | ﹤0.01% | 2007 |
|
|
2017
Q4 | $404K | Hold |
7,499
| – | – | ﹤0.01% | 1966 |
|
|
2017
Q3 | $435K | Hold |
7,499
| – | – | ﹤0.01% | 1955 |
|
|
2017
Q2 | $370K | Sell |
7,499
-9,751
| -57% | -$449K | ﹤0.01% | 2026 |
|
|
2017
Q1 | $749K | Hold |
17,250
| – | – | ﹤0.01% | 1496 |
|
|
2016
Q4 | $845K | Buy |
17,250
+10,018
| +139% | +$463K | ﹤0.01% | 1430 |
|
|
2016
Q3 | $346 | Hold |
7,232
| – | – | ﹤0.01% | 1956 |
|
|
2016
Q2 | $388K | Hold |
7,232
| – | – | ﹤0.01% | 1863 |
|
|
2016
Q1 | $323K | Hold |
7,232
| – | – | ﹤0.01% | 1956 |
|
|
2015
Q4 | $276K | Hold |
7,232
| – | – | ﹤0.01% | 2097 |
|
|
2015
Q3 | $230K | Sell |
7,232
-2,087
| -22% | -$72.8K | ﹤0.01% | 2196 |
|
|
2015
Q2 | $308K | Hold |
9,319
| – | – | ﹤0.01% | 2242 |
|
|
2015
Q1 | $384K | Hold |
9,319
| – | – | ﹤0.01% | 2091 |
|
|
2014
Q4 | $380K | Hold |
9,319
| – | – | ﹤0.01% | 2113 |
|
|
2014
Q3 | $342K | Sell |
9,319
-1,259
| -12% | -$54.4K | ﹤0.01% | 2167 |
|
|
2014
Q2 | $490K | Sell |
10,578
-4,028
| -28% | -$179K | ﹤0.01% | 1999 |
|
|
2014
Q1 | $600K | Hold |
14,606
| – | – | ﹤0.01% | 1839 |
|
|
2013
Q4 | $557K | Hold |
14,606
| – | – | ﹤0.01% | 1880 |
|
|
2013
Q3 | $350K | Hold |
14,606
| – | – | ﹤0.01% | 2184 |
|
|
2013
Q2 | $248K | Buy |
+14,606
| New | +$211K | ﹤0.01% | 2379 |
|
Other funds holding ANIK
TI
CP
AFA
BFM
CM
VOYA Investment Management's ANIK Position: Q4 2024 in Review
VOYA Investment Management sold out of Anika Therapeutics (ANIK) in Q4 2024, closing a stake of 9,960 shares — an estimated $246K sold.
VOYA Investment Management first reported a position in ANIK in Q2 2013 and held it in 37 quarters. The position peaked at $845K in Q4 2016. 109 funds tracked by Wall St. Rank hold ANIK as of Q4 2024.
- VOYA Investment Management reported no remaining Anika Therapeutics position as of Q4 2024 after selling out during the quarter.
- VOYA Investment Management sold 9,960 Anika Therapeutics shares in Q4 2024, an estimated $246K.
- VOYA Investment Management first reported a position in Anika Therapeutics in Q2 2013 and held it in 37 quarters.
- VOYA Investment Management's Anika Therapeutics position peaked at $845K in Q4 2016.
- 109 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2024.
Based on VOYA Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.